IBM Research, UCSD collaborate on artificial intelligence for healthy living

Friday, September 29, 2017

IBM and the University of California San Diego have announced a multi-year project to enhance quality of life and independence for aging populations through the new Artificial Intelligence for Healthy Living Center (AIHL), located on the campus of UC San Diego. The groundbreaking center will bring together the technology, artificial intelligence and life sciences knowledge of IBM and UC San Diego to promote critical research and applications in two thematic areas: Healthy Aging and the Human Microbiome.

[Read More]

IBM, Rensselaer Polytechnic Institute to research chronic diseases with cognitive computing

Friday, May 19, 2017

IBM and Rensselaer Polytechnic Institute announced the creation of the new Center for Health Empowerment by Analytics, Learning, and Semantics (HEALS). Located on the Rensselaer campus, the HEALS center is a five-year collaborative research effort aimed at researching how the application of advanced cognitive computing capabilities can help people to understand and improve their own health conditions.

[Read More]

IBM uses Big Data to develop new strategies to help address Ebola

Friday, May 5, 2017

IBM has used big data analytics to assess the impact of infected animal carriers, or an animal reservoir, in the spread of the Ebola virus in a way not been previously done for earlier disease models. Direct contact with the infected animal—most likely a bat or large snake—whether by touching or eating it—can cause the disease to enter the human population, and then spread.

[Read More]

Lundbeck, IBM Watson Health collaborate on neurological disorders

Monday, January 30, 2017

Lundbeck is collaborating with IBM‘s Watson Health to accelerate the development of innovative medicines to treat psychiatric and neurological disorders. The collaboration will combine Lundbeck’s expertise in the treatment of psychiatric and neurological disorders with IBM’s cognitive and knowledge-based analytics to foster the discovery and development of new innovative treatments of disorders such as schizophrenia and Parkinson’s disease.

[Read More]